Image-guided percutaneous thermal ablation for the palliative treatment of chest wall masses

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 4, 2007, Pages 361-367

  Grieco, C Alexander ^a   Simon, Caroline J ^a   Mayo Smith, William W ^a   Dipetrillo, Thomas A ^a   Ready, Neal E ^a   Dupuy, Damian E ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALGESIA; ARTICLE; BRACHIAL PLEXUS NEUROPATHY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; CRYOABLATION; DISEASE EXACERBATION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; MALE; MICROWAVE THERAPY; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; SURVIVAL TIME; THORAX WALL TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CATHETER ABLATION; CRYOTHERAPY; FEMALE; FLUOROSCOPY; HUMANS; HYPERTHERMIA, INDUCED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PAIN MEASUREMENT; PALLIATIVE CARE; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; THORACIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34548436117     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318033e76a     Document Type: Article

References (41)

1. Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80:1588-1594.
2. Paget S. The distribution of secondary growths in cancer of the breast. Lancet. 1889;1:571-573.
3. Roodman DG. Mechanisms of bone metastasis. N Engl J Med. 2004;350:1655-1664.
4. Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987;55:61-66.
5. Clohisy DR, Mantyh PW. Bone cancer pain. Clin Orthop. 2003;415(suppl):279-288.
6. Janjan NA, Payne R, Gillis T, et al. Presenting symptoms in patients referred to a multidisciplinary clinic for bone metastases. J Pain Symptom Manage. 1998;16:171-178.
7. Janjan NA. Bone metastases: approaches to management. Semin Oncol. 2001;28:28-34.
8. Janjan NA. Radiation for bone metastases: conventional techniques and the role of systemic radiopharmaceuticals. Cancer. 1997;80(suppl 5):1628-1645.
9. Frassica DA. General principles of external beam radiation therapy for skeletal metastases. Clin Orthop. 2003;415(suppl):158-164.
10. Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer. 1982;50:893-899.
11. Cleeland CS, Gronin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1996;330:592-596.
12. Miaskowski C, Nichols R, Brody R, et al. Assessment of patient satisfaction utilizing the American Pain Society's Quality Assurance Standards on acute and cancer-related pain. J Pain Symptom Manage. 1994;9:5-11.
13. Von Gunten CF, Von Roenn JH. Barriers to pain control: ethics and knowledge. J Palliat Care. 1994;10:52-54.
14. Dupuy DE, Safran H, Mayo-Smith WW, et al. Radiofrequency ablation of painful osseous metastatic disease [abstract]. Radiology. 2000;209:389.
15. Callstrom MR, Charboneau JW, Goetz MP, et al. Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radiofrequency ablation. Radiology. 2002;224:87-97.
16. Goetz MP, Callstrom MR, Charboneau JW, et al. Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol. 2004;22:300-306.
17. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005;325:728-739.
18. DiPetrillo TA, Dupuy DE. Radiofrequency ablation and radiotherapy: complimenting treatments for solid tumors. Semin Intervent Radiol. 2003;20:341-345.
19. Hall E. Radiobiology for the Radiologist, 5th ed. Philadelphia: Lippincott, Williams & Wilkins, 2000.
20. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101:3-27.
21. Bonomi P, Kim KM, Fairclough D, et al. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J Clin Oncol. 2000;18:623-631.
22. Portenoy RK, Miransky J, Thaler HT, et al. Pain in ambulatory patients with lung or colon cancer. Cancer. 1992;70:1616-1624.
23. Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunities - part I. J Vasc Interv Radiol. 2001;12:1021-1032.
24. Dupuy DE, Goldberg SN. Image-guided radiofrequency tumor ablation: challenges and opportunities - part II. J Vasc Interv Radiol. 2001;12:1135-1148.
25. Steinke K, Sewell PE, Dupuy DE. Pulmonary radiofrequency ablation: an international study survey. Anticancer Res. 2004;24:339-343.
26. Kvale PA, Simoff M, Prakash UBS. Palliative care. Chest. 2003;123(suppl):284-311.
27. Ratanatharathorn V, Powers WE, Moss WT, et al. Bone metastasis: review and critical analysis of random allocation trials of local field treatment. Int J Radiat Onc Biol Phys. 1999;44:1-18.
28. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage. 2003;25:406-411.
29. Farrar JT, Portenoy RK, Berlin JA, et al. Defining the clinically important difference in pain outcome measures. Pain. 2000;88:287-294.
30. Berstein SL, Bijur PE, Gallagher EJ. Relationship between intensity and relief in patients with acute severe pain. Am J Emerg Med. 2006;24:162-166.
31. Bromm B. The measurement of pain in man. In: Bromm B, ed. Pain Measurement in Man. Amsterdam: Elsevier, 1984:3-13.
32. Mach DB, Rogers SD, Sabino MAC, et al. Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur. Neuroscience. 2002;113:156-166.
33. Honore P, Rogers SD, Schwei MJ, et al. Murine models of inflammatory, neuropathic, and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience. 2000;98:585-598.
34. Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology. 2002;223:331-337.
35. Lee FT Jr, Chosy SG, Littrup JP, et al. CT-monitored percutaneous cryoablation in a pig liver model: pilot study. Radiology. 1999;211:687-692.
36. Friedman MA, Altemus R, Wood BJ. Radiofrequency ablation in a previously irradiated liver. J Vasc Interv Radiol. 2003;14:1345-1348.
37. Horkan C, Dalal K, Coderre JA, et al. Reduced tumor growth with combined radiofrequency ablation and radiation therapy in a rat breast tumor model. Radiology. 2005;235:81-88.
38. Dupuy DE, DiPetrillo T, Gandhi S, et al. Radiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancer. Chest. 2006;129:738-745.
39. Rustoen T, Moum T, Padilla G, et al. Predictors of quality of life in oncology outpatients with pain from bone metastasis. J Pain Symptom Manage. 2005;30:234-242.
40. Lillemoe KD, Cameron JL, Kaufman HS, et al. Chemical splanchnicectomy in patients with unresectable pancreatic cancer: a prospective randomized trial. Ann Surg. 1993;217:447-455.
41. Smith TJ, Staats PS, Stearns LJ, et al. Implantable Drug Delivery Systems Study Group. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol. 2002;20:4040-4049.